Combination of MPPa-PDT and HSV1-TK/GCV gene therapy on prostate cancer.
about
Combination of MPPa-PDT and HSV1-TK/GCV gene therapy on prostate cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Combination of MPPa-PDT and HSV1-TK/GCV gene therapy on prostate cancer.
@en
Combination of MPPa-PDT and HSV1-TK/GCV gene therapy on prostate cancer.
@nl
type
label
Combination of MPPa-PDT and HSV1-TK/GCV gene therapy on prostate cancer.
@en
Combination of MPPa-PDT and HSV1-TK/GCV gene therapy on prostate cancer.
@nl
prefLabel
Combination of MPPa-PDT and HSV1-TK/GCV gene therapy on prostate cancer.
@en
Combination of MPPa-PDT and HSV1-TK/GCV gene therapy on prostate cancer.
@nl
P2093
P2860
P1476
Combination of MPPa-PDT and HSV1-TK/GCV gene therapy on prostate cancer.
@en
P2093
Liming Liang
Weiwen Chen
Wenxiang Bi
Yuanyuan Tian
P2860
P2888
P356
10.1007/S10103-017-2331-6
P577
2018-01-06T00:00:00Z